Streetbeat News

Stock Prices

BMBL

CDLX

GVP

LLY

OM

VSAT

XPEL

U.S. stocks surged with the Dow Jones gaining over 500 points. Eli Lilly reported strong Q2 earnings and raised its full-year guidance. XPEL, Viasat, and GSE Systems saw significant stock price increases due to positive earnings and acquisition news, while Cardlytics, Outset Medical, and Bumble experienced sharp declines following disappointing earnings.

Portfolio Pulse from Avi Kapoor

August 08, 2024 | 4:06 pm

GDRX

GoodRx Holdings Inc. (NASDAQ:GDRX) reported Q2 revenue of $200.61 million, up 6% YoY, with prescription transactions revenue increasing by 7%. However, subscription revenue decreased by 8% due to the end of the Kroger Savings Club partnership. Adjusted EPS was 8 cents, missing the consensus of 9 cents. The company expects FY 2024 revenue at the lower end of $800M-$810M and Q3 revenue between $193M-$197M, below the consensus of $202.4M. GDRX stock is down 21.1% at $6.79.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 4:04 pm

LMT

Deep-pocketed investors have adopted a bearish approach towards Lockheed Martin (NYSE:LMT), as revealed by Benzinga's options scanner. The scanner highlighted 9 extraordinary options activities, with 33% bullish and 44% bearish sentiment. Significant trades include puts totaling $127,290 and calls amounting to $553,750. Analysts have mixed ratings, with price targets ranging from $500 to $600.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:01 pm

FTAI

FTAI Aviation (NASDAQ:FTAI) has received a mix of bullish and somewhat bullish ratings from 15 analysts over the past quarter. Analysts have raised their 12-month price targets, with an average target of $106.93, reflecting a 15.23% increase from the previous average. Despite positive revenue growth, the company faces challenges with profitability, return on equity, and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:01 pm

ACMR

ACM Research (NASDAQ:ACMR) has significantly outperformed the market over the past 5 years, delivering an average annual return of 26.07%. A $100 investment in ACMR 5 years ago would be worth $327.64 today. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

PNTG

Pennant Group Inc (NASDAQ:PNTG) has been analyzed by 4 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target is $28.0, with a high of $34.00 and a low of $25.00. Recent analyst actions include rating upgrades and price target increases, reflecting positive sentiment. The company has shown strong financial performance with significant revenue growth, high net margins, and strong ROE and ROA, but faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has significantly outperformed the market over the past 10 years, delivering an average annual return of 27.23%. A $100 investment in PANW 10 years ago would be worth $1,159.30 today. The company's current market capitalization is $101.68 billion.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

UMH

UMH Properties (NYSE:UMH) has been analyzed by 4 analysts, revealing mixed sentiments. The average 12-month price target is $19.12, up 9.26% from the previous $17.50. Analysts' ratings range from 'Neutral' to 'Buy', with price targets between $17.00 and $21.00. UMH Properties has shown strong revenue growth but faces challenges with profitability, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

DVAX

Dynavax Technologies (NASDAQ:DVAX) has been analyzed by 4 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target is $25.5, down 4.67% from the previous $26.75. Key analysts include Paul Choi from Goldman Sachs, who lowered his target to $15.00, and Edward White from HC Wainwright & Co., who maintained a $29.00 target. Dynavax has shown positive revenue growth and strong financial performance, but its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 4:00 pm

DIS

Analysts have mixed views on The Walt Disney Company's (NYSE:DIS) recent performance, with concerns about theme park weakness offset by strong streaming profits. Multiple analysts have reiterated Buy ratings but lowered their price targets. The focus is on the normalization of theme park profitability and the strength of Disney's Direct-to-Consumer (DTC) segment.

Portfolio Pulse from Chris Katje

August 08, 2024 | 3:58 pm